Palliative Care in Huntington Disease: Personal Reflections and a Review of the Literature
Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is...
Saved in:
Published in | Tremor and other hyperkinetic movements (New York, N.Y.) Vol. 7; p. 454 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Columbia University Libraries/Information Services
01.01.2017
Ubiquity Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is an approach to care that focuses on symptom relief, patient and caregiver support, and end of life care. There is increasing evidence of the benefit of palliative care throughout the course of neurodegenerative conditions including Parkinson disease and amyotrophic lateral sclerosis. However, beyond its application at the end of life, little is known about the role of palliative care in Huntington disease.
In this article, we discuss what is known about palliative care in Huntington disease, specifically related to early disease burden, caregiver burnout, advance care planning, and end of life care.
We provide a review of the current literature and discuss our own care practices.
We conclude by discussing questions that remain unanswered and positing ideas for future work in the field. |
---|---|
AbstractList | Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is an approach to care that focuses on symptom relief, patient and caregiver support, and end of life care. There is increasing evidence of the benefit of palliative care throughout the course of neurodegenerative conditions including Parkinson disease and amyotrophic lateral sclerosis. However, beyond its application at the end of life, little is known about the role of palliative care in Huntington disease.BACKGROUNDHuntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is an approach to care that focuses on symptom relief, patient and caregiver support, and end of life care. There is increasing evidence of the benefit of palliative care throughout the course of neurodegenerative conditions including Parkinson disease and amyotrophic lateral sclerosis. However, beyond its application at the end of life, little is known about the role of palliative care in Huntington disease.In this article, we discuss what is known about palliative care in Huntington disease, specifically related to early disease burden, caregiver burnout, advance care planning, and end of life care.METHODSIn this article, we discuss what is known about palliative care in Huntington disease, specifically related to early disease burden, caregiver burnout, advance care planning, and end of life care.We provide a review of the current literature and discuss our own care practices.RESULTSWe provide a review of the current literature and discuss our own care practices.We conclude by discussing questions that remain unanswered and positing ideas for future work in the field.DISCUSSIONWe conclude by discussing questions that remain unanswered and positing ideas for future work in the field. Background Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is an approach to care that focuses on symptom relief, patient and caregiver support, and end of life care. There is increasing evidence of the benefit of palliative care throughout the course of neurodegenerative conditions including Parkinson disease and amyotrophic lateral sclerosis. However, beyond its application at the end of life, little is known about the role of palliative care in Huntington disease.Methods In this article, we discuss what is known about palliative care in Huntington disease, specifically related to early disease burden, caregiver burnout, advance care planning, and end of life care.Results We provide a review of the current literature and discuss our own care practices.Discussion We conclude by discussing questions that remain unanswered and positing ideas for future work in the field. Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is an approach to care that focuses on symptom relief, patient and caregiver support, and end of life care. There is increasing evidence of the benefit of palliative care throughout the course of neurodegenerative conditions including Parkinson disease and amyotrophic lateral sclerosis. However, beyond its application at the end of life, little is known about the role of palliative care in Huntington disease. In this article, we discuss what is known about palliative care in Huntington disease, specifically related to early disease burden, caregiver burnout, advance care planning, and end of life care. We provide a review of the current literature and discuss our own care practices. We conclude by discussing questions that remain unanswered and positing ideas for future work in the field. |
Author | Chesire, Amy M Tarolli, Christopher G Biglan, Kevin M |
AuthorAffiliation | 2 Early Phase Clinical Development, Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA Yale University, USA 1 Department of Neurology, University of Rochester, Rochester, NY, USA |
AuthorAffiliation_xml | – name: Yale University, USA – name: 1 Department of Neurology, University of Rochester, Rochester, NY, USA – name: 2 Early Phase Clinical Development, Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA |
Author_xml | – sequence: 1 givenname: Christopher G surname: Tarolli fullname: Tarolli, Christopher G organization: Department of Neurology, University of Rochester, Rochester, NY, USA – sequence: 2 givenname: Amy M surname: Chesire fullname: Chesire, Amy M organization: Department of Neurology, University of Rochester, Rochester, NY, USA – sequence: 3 givenname: Kevin M surname: Biglan fullname: Biglan, Kevin M organization: Early Phase Clinical Development, Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28428907$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkUtvFDEQhC0URB5E4hcgH7ks-DEztjkgoU1IIq1EhODCxWrbPRtHs3awPYv49wwkoKQvXapufXWoY3KQckJCXnH2Vhk-vDvTmvVqrZ6RI8EHttJC64NH-pCc1nrLlumVEV3_ghwK3QltmDoi369hmiK0uEe6hoI0Jno5pxbTtuVEz2JFqPieXmOpOcFEv-A4oW8xp0ohBQqLs4_4k-aRthukm9iwQJsLviTPR5gqnj7sE_Lt0_nX9eVq8_niav1xswpSirbqtYDBCKWY8ZyPGlTwoxoX7bpRM-aEkn7wIqjeMIkDgJOMB82cdgGckyfk6p4bMtzauxJ3UH7ZDNH-NXLZWigt-gmtY2jcyEEI7zsHwfUmOOTeGOmE9mZhfbhn3c1uh8FjagWmJ9CnlxRv7DbvbS9NP6g_gDcPgJJ_zFib3cXqcZogYZ6r5dpw3jFtuuX19eOs_yH_ypG_AYo3k_8 |
ContentType | Journal Article |
Copyright | 2017 Tarolli et al. 2017 Tarolli et al. |
Copyright_xml | – notice: 2017 Tarolli et al. 2017 Tarolli et al. |
DBID | NPM 7X8 5PM DOA |
DOI | 10.7916/D88057C7 |
DatabaseName | PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ: Directory of Open Access Journal (DOAJ) |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Palliative Care in Huntington Disease |
EISSN | 2160-8288 |
ExternalDocumentID | oai_doaj_org_article_b0e9bf1a22cc4badb59dbe1c993b28c9 PMC5395679 28428907 |
Genre | Journal Article Review |
GroupedDBID | .0O 53G 5VS 7X7 8FI 8FJ AAFWJ ABUWG ADBBV ADRAZ AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR CCPQU DIK DWQXO EMOBN FRJ FYUFA GNUQQ GROUPED_DOAJ H13 HMCUK HYE KQ8 M2M M48 M~E NPM OK1 PGMZT PIMPY PSYQQ RPM UKHRP 7X8 PHGZM PHGZT 5PM PUEGO |
ID | FETCH-LOGICAL-d332t-582a6927709c11f8a7dcf7fc11b4f800b273c6c2d75903e6aab301d80b8bdabb3 |
IEDL.DBID | M48 |
ISSN | 2160-8288 |
IngestDate | Wed Aug 27 01:31:30 EDT 2025 Thu Aug 21 18:26:20 EDT 2025 Thu Jul 10 22:24:45 EDT 2025 Thu Jan 02 22:25:29 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | hospice advance care planning palliative care caregiver burden Huntington disease |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution–Noncommerical–No Derivatives License, which permits the user to copy, distribute, and transmit the work provided that the original author and source are credited; that no commercial use is made of the work; and that the work is not altered or transformed. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-d332t-582a6927709c11f8a7dcf7fc11b4f800b273c6c2d75903e6aab301d80b8bdabb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.7916/D88057C7 |
PMID | 28428907 |
PQID | 1891140894 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b0e9bf1a22cc4badb59dbe1c993b28c9 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5395679 proquest_miscellaneous_1891140894 pubmed_primary_28428907 |
PublicationCentury | 2000 |
PublicationDate | 2017-01-01 |
PublicationDateYYYYMMDD | 2017-01-01 |
PublicationDate_xml | – month: 01 year: 2017 text: 2017-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Tremor and other hyperkinetic movements (New York, N.Y.) |
PublicationTitleAlternate | Tremor Other Hyperkinet Mov (N Y) |
PublicationYear | 2017 |
Publisher | Columbia University Libraries/Information Services Ubiquity Press |
Publisher_xml | – name: Columbia University Libraries/Information Services – name: Ubiquity Press |
References | 24195904 - Am J Occup Ther. 2013 Nov-Dec;67(6):704-10 15008126 - J Palliat Med. 2004 Feb;7(1):19-25 25411649 - Tremor Other Hyperkinet Mov (N Y). 2014 Nov 12;4:257 19415556 - Health Commun. 2009 Apr;24(3):239-48 22867994 - Parkinsonism Relat Disord. 2012 Dec;18 Suppl 3:S6-9 8108531 - Psychol Med. 1993;Suppl 23:1-46 25728958 - Lancet Neurol. 2015 Apr;14(4):435-42 25330167 - JAMA Intern Med. 2014 Dec;174(12):1994-2003 19639395 - J Clin Psychol Med Settings. 2009 Dec;16(4):355-62 26447070 - JBI Database System Rev Implement Rep. 2015 May 15;13(4):14-29 26150131 - Cancer. 2015 Oct 15;121(20):3737-45 24618967 - JAMA. 2014 Mar 12;311(10):1052-60 154626 - Neurology. 1979 Jan;29(1):1-3 16467346 - BMJ. 2006 Mar 4;332(7540):515-21 22477667 - J Cancer Educ. 2012 Jun;27(3):515-20 24052430 - Am J Hosp Palliat Care. 2015 Feb;32(1):68-77 23698451 - Palliat Med. 2013 Dec;27(10):918-24 19276225 - Chronic Illn. 2009 Mar;5(1):46-55 24991027 - Neurology. 2014 Aug 5;83(6):561-7 25806882 - Oncol Nurs Forum. 2015 Mar;42(2):156-64 26918202 - Neurol Clin Pract. 2016 Feb;6(1):40-48 8866495 - Mov Disord. 1996 Sep;11(5):542-8 11176966 - Arch Neurol. 2001 Feb;58(2):273-8 8657216 - N Engl J Med. 1996 Jul 18;335(3):172-8 27938026 - J Soc Work End Life Palliat Care. 2016 Oct-Dec;12 (4):348-365 20423385 - J Adv Nurs. 2010 Mar;66(3):500-10 8291568 - Am J Med Genet. 1993 Oct 15;48(3):145-50 20818875 - N Engl J Med. 2010 Aug 19;363(8):733-42 22692795 - Mov Disord. 2012 Aug;27(9):1083-91 20078215 - J Palliat Med. 2010 Mar;13(3):267-71 24964036 - PLoS One. 2014 Jun 25;9(6):e100435 18070848 - J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):441-8 18581443 - Mov Disord. 2008 Aug 15;23(11):1491-504 18619087 - Care Manag J. 2008;9(2):75-81 23876040 - J Palliat Med. 2013 Aug;16(8):818-9 26688844 - Psychiatr Pol. 2015 ;49(5):931-44 23175514 - Palliat Med. 2013 May;27(5):389-400 22761268 - Cleve Clin J Med. 2012 Jul;79 Suppl 2:S30-4 7806741 - J Am Geriatr Soc. 1995 Jan;43(1):56-9 9532400 - Camb Q Healthc Ethics. 1998 Spring;7(2):206-7 18175350 - Mov Disord. 2008 Apr 15;23(5):721-6 9288011 - J Am Geriatr Soc. 1997 Sep;45(9):1054-9 21538527 - Mov Disord. 2011 Aug 1;26(9):1711-6 24126537 - JAMA Neurol. 2013 Dec;70(12 ):1520-30 10605972 - JAMA. 1999 Dec 15;282(23):2215-9 16387989 - J Neuropsychiatry Clin Neurosci. 2005 Fall;17(4):496-502 24152480 - Br J Gen Pract. 2013 Oct;63(615):e657-68 21707857 - Psychogeriatrics. 2011 Jun;11(2):98-104 17491500 - Clin Med (Lond). 2007 Apr;7(2):129-36 |
References_xml | – reference: 11176966 - Arch Neurol. 2001 Feb;58(2):273-8 – reference: 18619087 - Care Manag J. 2008;9(2):75-81 – reference: 22761268 - Cleve Clin J Med. 2012 Jul;79 Suppl 2:S30-4 – reference: 16467346 - BMJ. 2006 Mar 4;332(7540):515-21 – reference: 22692795 - Mov Disord. 2012 Aug;27(9):1083-91 – reference: 21707857 - Psychogeriatrics. 2011 Jun;11(2):98-104 – reference: 25411649 - Tremor Other Hyperkinet Mov (N Y). 2014 Nov 12;4:257 – reference: 22867994 - Parkinsonism Relat Disord. 2012 Dec;18 Suppl 3:S6-9 – reference: 17491500 - Clin Med (Lond). 2007 Apr;7(2):129-36 – reference: 8108531 - Psychol Med. 1993;Suppl 23:1-46 – reference: 25330167 - JAMA Intern Med. 2014 Dec;174(12):1994-2003 – reference: 20078215 - J Palliat Med. 2010 Mar;13(3):267-71 – reference: 19415556 - Health Commun. 2009 Apr;24(3):239-48 – reference: 24991027 - Neurology. 2014 Aug 5;83(6):561-7 – reference: 27938026 - J Soc Work End Life Palliat Care. 2016 Oct-Dec;12 (4):348-365 – reference: 9532400 - Camb Q Healthc Ethics. 1998 Spring;7(2):206-7 – reference: 20423385 - J Adv Nurs. 2010 Mar;66(3):500-10 – reference: 26918202 - Neurol Clin Pract. 2016 Feb;6(1):40-48 – reference: 26150131 - Cancer. 2015 Oct 15;121(20):3737-45 – reference: 24195904 - Am J Occup Ther. 2013 Nov-Dec;67(6):704-10 – reference: 23698451 - Palliat Med. 2013 Dec;27(10):918-24 – reference: 16387989 - J Neuropsychiatry Clin Neurosci. 2005 Fall;17(4):496-502 – reference: 18070848 - J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):441-8 – reference: 24052430 - Am J Hosp Palliat Care. 2015 Feb;32(1):68-77 – reference: 25728958 - Lancet Neurol. 2015 Apr;14(4):435-42 – reference: 25806882 - Oncol Nurs Forum. 2015 Mar;42(2):156-64 – reference: 19276225 - Chronic Illn. 2009 Mar;5(1):46-55 – reference: 24126537 - JAMA Neurol. 2013 Dec;70(12 ):1520-30 – reference: 22477667 - J Cancer Educ. 2012 Jun;27(3):515-20 – reference: 8291568 - Am J Med Genet. 1993 Oct 15;48(3):145-50 – reference: 24152480 - Br J Gen Pract. 2013 Oct;63(615):e657-68 – reference: 18581443 - Mov Disord. 2008 Aug 15;23(11):1491-504 – reference: 26688844 - Psychiatr Pol. 2015 ;49(5):931-44 – reference: 10605972 - JAMA. 1999 Dec 15;282(23):2215-9 – reference: 154626 - Neurology. 1979 Jan;29(1):1-3 – reference: 15008126 - J Palliat Med. 2004 Feb;7(1):19-25 – reference: 24964036 - PLoS One. 2014 Jun 25;9(6):e100435 – reference: 8657216 - N Engl J Med. 1996 Jul 18;335(3):172-8 – reference: 21538527 - Mov Disord. 2011 Aug 1;26(9):1711-6 – reference: 19639395 - J Clin Psychol Med Settings. 2009 Dec;16(4):355-62 – reference: 8866495 - Mov Disord. 1996 Sep;11(5):542-8 – reference: 26447070 - JBI Database System Rev Implement Rep. 2015 May 15;13(4):14-29 – reference: 24618967 - JAMA. 2014 Mar 12;311(10):1052-60 – reference: 23876040 - J Palliat Med. 2013 Aug;16(8):818-9 – reference: 7806741 - J Am Geriatr Soc. 1995 Jan;43(1):56-9 – reference: 18175350 - Mov Disord. 2008 Apr 15;23(5):721-6 – reference: 9288011 - J Am Geriatr Soc. 1997 Sep;45(9):1054-9 – reference: 23175514 - Palliat Med. 2013 May;27(5):389-400 – reference: 20818875 - N Engl J Med. 2010 Aug 19;363(8):733-42 |
SSID | ssj0000579245 |
Score | 2.1007407 |
SecondaryResourceType | review_article |
Snippet | Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and... Background Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances,... |
SourceID | doaj pubmedcentral proquest pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 454 |
SubjectTerms | Reviews |
SummonAdditionalLinks | – databaseName: DOAJ: Directory of Open Access Journal (DOAJ) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA6yB_Eivl1fRPBats2jabz5ZBGVRRQWLyWTBwrSFV3_v5Omyq4IXoSe2kOHmUnmm5nkG0KOhPdSBVtkKjCZCfSYDGTJM_CiyB1X3oRY77i5LYcP4mosxzOjvuKZsEQPnBQ3gNxrCIVhzFoBxoHUDnxhMa4Cq2x7dQ9j3kwylVi9FSYWMrHNKoRAg3N0VKnOVMfN_xug_HkucibQXK6Q5Q4h0pMk2SpZ8M0aWbzpeuDr5HFkYokkblM03h6izw0dpoEPiOPoeeq4HNNRB7PpnQ8v7YGr5p2axlFDU0OATgJF-Eevv5mVN8jD5cX92TDrJiRkjnM2zWTFTKmZUrm2RREqo5wNUfUFiIBQEBCc2NIyp6TOuS-NAVzQrsqhAmcA-CbpNZPGbxOa86DwcSxoLjzuPQh1vJDM5NyA1VWfnEa91a-JBKOOtNTtCzRW3Rmr_stYfXL4pfUa3Tj2JkzjJx_vdVHhrivySos-2UpW-P4VRtDYDlV9oubsMyfL_Jfm-amlypYc8z-ld_5D-F2yxGJMb-sve6Q3ffvw-4hIpnDQOt8nEXvjjg priority: 102 providerName: Directory of Open Access Journals |
Title | Palliative Care in Huntington Disease: Personal Reflections and a Review of the Literature |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28428907 https://www.proquest.com/docview/1891140894 https://pubmed.ncbi.nlm.nih.gov/PMC5395679 https://doaj.org/article/b0e9bf1a22cc4badb59dbe1c993b28c9 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3La9tAEIeHPKD0UtK3k9ZsoVel0j402l5K88KUOphQg-lF7DMNBLmxHWj_-85KcqhDTgGdJBaJndndb3ZWvwH4KENQGF2RYeQqk-QxmVWlyGyQRe4FBhPTfsf4vBxN5beZmm3Butpm34HLB0O7VE9qurg-_HPz9wsNeOLXQyS6-XRCPqjwGLdhl9YjTHUMxj3kdwrfSEGG6pRnNxokJeBKplQb9pL9D3Hm_eOS_60_Z3vwrAdH9rWz9HPYCs0LeDLuU-Mv4efEpJ2TNHux9FMRu2rYqKsDQXjHTrpEzGc26embXYR43Z7DapbMNJ4Z1uUJ2DwyokL2_U5w-RVMz05_HI-yvnBC5oXgq0xV3JSaI-baFUWsDHoXk0UKKyMRoiVmcaXjHpXORSiNsTTOfZXbynpjrXgNO828CW-B5SIiXZ5HLWSgKYkIKEjFTS6MdboawFHqt_p3p41RJ7Xq9sZ8cVn3zl_bPGgbC8O5c9Iab5X2NhSO2MjyyukBfFj3ek3enVIWpgnz22VdVDQZy7zScgBvOivcvWptugHghn02vmXzSXP1q1XQVoLCQtT7j255AE95Wt_bvZh3sLNa3Ib3RCcrO4RtnOEQdo9OzycXwzbGH7YO-Q-PZesr |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Palliative+Care+in+Huntington+Disease%3A+Personal+Reflections+and+a+Review+of+the+Literature&rft.jtitle=Tremor+and+other+hyperkinetic+movements+%28New+York%2C+N.Y.%29&rft.au=Tarolli%2C+Christopher+G.&rft.au=Chesire%2C+Amy+M.&rft.au=Biglan%2C+Kevin+M.&rft.date=2017-01-01&rft.pub=Columbia+University+Libraries%2FInformation+Services&rft.eissn=2160-8288&rft.volume=7&rft_id=info:doi/10.7916%2FD88057C7&rft_id=info%3Apmid%2F28428907&rft.externalDocID=PMC5395679 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2160-8288&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2160-8288&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2160-8288&client=summon |